Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). (Q40220985)
Jump to navigation
Jump to search
scientific article published on January 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231). |
scientific article published on January 2007 |
Statements
Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231) (English)
Daisuke Takabatake
Takeo Fujita
Kensuke Kawasaki
Naruto Taira
Seiji Yoshitomi
Hirotoshi Takahashi
Yoichi Ishibe
Yutaka Ogasawara
Hiroyoshi Doihara
1 January 2007